Extended naltrexone and broad spectrum treatment or motivational enhancement therapy

Psychopharmacology

Volumn 206, Issue 3, 2009, Pages 367-376

  Longabaugh, Richard ^a   Wirtz, Philip W ^b   Gulliver, Suzy Bird ^c   Davidson, Dena ^d  

^a BROWN UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Alcohol dependence; Broad spectrum treatment; Motivational enhancement therapy; Naltrexone

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOTIVATIONAL ENHANCEMENT THERAPY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NALTREXONE; NARCOTIC ANTAGONISTS; TEMPERANCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349561348     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1615-3     Document Type: Article

References (50)

1. RF Anton DH Moak P Latham LR Waid H Myrick K Voronin A Thevos W Wang R Woolson 2005 Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence J Clin Psychopharmacol 25 349 357 16012278 10.1097/01.jcp.0000172071.81258.04 1:CAS:528: DC%2BD2MXmtVahsrw%3D (Pubitemid 41060255)
2. RF Anton DH Moak PK Latham LR Waid RJ Malcolm JK Dias JS Roberts 2001 Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism J Clin Psychopharmacol 21 72 77 11199951 10.1097/00004714-200102000-00013 1:CAS:528:DC%2BD3MXptlKktw%3D%3D (Pubitemid 32096753)
3. RF Anton DH Moak LR Waid PK Latham RJ Malcolm JK Dias 1999 Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial Am J Psychiatry 156 1758 1764 10553740 1:STN:280:DC%2BD3c%2FhvFWlug%3D%3D
4. RF Anton SS O'Malley DA Ciraulo RA Cisler D Couper DM Donovan DR Gastfriend JD Hosking BA Johnson JS LoCastro R Longabaugh BJ Mason ME Mattson WR Miller HM Pettinati CL Randall R Swift RD Weiss LD Williams A Zweben 2006 Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA 295 2003 2017 16670409 10.1001/jama.295.17.2003 1:CAS:528:DC%2BD28Xkt12mtrc%3D (Pubitemid 44794003)
5. J Balldin M Berglund S Borg M Mansson P Bendtsen J Franck L Gustafsson J Halldin LH Nilsson G Stolt A Willander 2003 A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence Alcohol Clin Exp Res 27 1142 1149 12878920 10.1097/01.ALC.0000075548.83053.A9 1:CAS:528:DC%2BD3sXlvFartLo%3D (Pubitemid 36890391)
6. MC Beattie R Longabaugh J Fava 1992 Assessment of alcohol-related workplace activities: development and testing of 'your workplace' J Stud Alcohol 53 469 475 1405640 1:STN:280:DyaK3s%2Fit1OitQ%3D%3D
7. RHB Benedict D Schretlen L Groninger 1998 Hopkins Verbal Learning Test-revised: normative data and analysis of interform and test-retest reliability Clin Neuropsychol 12 43 55 10.1037/0894-4105.12.1.43 (Pubitemid 28070397)
8. L Biener DB Abrams 1991 The contemplation ladder: validation of a measure of readiness to consider smoking cessation Health Psychol 10 360 365 1935872 10.1037/0278-6133.10.5.360 1:STN:280:DyaK38%2FjslCqtg%3D%3D
9. J Chick R Anton K Checinski R Croop DC Drummond R Farmer D Labriola J Marshall J Moncrieff MY Morgan T Peters B Ritson 2000 A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse Alcohol Alcohol 35 587 593 11093966 1:CAS:528:DC%2BD3MXjsFClsA%3D%3D
10. D Davidson SB Gulliver R Longabaugh PW Wirtz R Swift 2007 Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone? J Stud Alcohol Drugs 68 238 247 17286342
11. D Davidson T Palfai C Bird R Swift 1999 Effects of naltrexone on alcohol self-administration in heavy drinkers Alcohol Clin Exp Res 23 195 203 10069545 1:CAS:528:DyaK1MXhslCms7Y%3D
12. D Davidson R Swift E Fitz 1996 Naltrexone increases the latency to drink alcohol in social drinkers Alcohol Clin Exp Res 20 732 739 8800392 10.1111/j.1530-0277.1996.tb01679.x 1:CAS:528:DyaK28XksVOktLY%3D (Pubitemid 26186942)
13. D Davidson PW Wirtz SB Gulliver R Longabaugh 2007 Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment Psychopharmacology (Berl) 194 1 10 10.1007/s00213-007-0807-y 1:CAS:528:DC%2BD2sXptFehu7k%3D (Pubitemid 47282730)
14. DM Donovan RF Anton WR Miller R Longabaugh JD Hosking M Youngblood 2008 Combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): examination of posttreatment drinking outcomes J Stud Alcohol Drugs 69 5 13 18080059
15. JM Donovan MR Elliott DF Heitjan 2007 Predicting event times in clinical trials when randomization is masked and blocked Clin Trials 4 481 490 17942464 10.1177/1740774507083390 (Pubitemid 350189872)
16. NB Epstein LM Baldwin DS Bishop 1983 The McMaster family assessment device J Marital Fam Ther 9 171 180 10.1111/j.1752-0606.1983.tb01497.x
17. First M, Spitzer RL, Gibbon M, Williams J (1996) Structured clinical interview for DSM-IV axis I disorders-patient edition (SCID-I/P-Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York
18. M Gastpar U Bonnet J Boning K Mann LG Schmidt M Soyka T Wetterling V Kielstein D Labriola R Croop 2002 Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study J Clin Psychopharmacol 22 592 598 12454559 10.1097/00004714-200212000-00009 1:CAS:528:DC%2BD38XptVShsL8%3D (Pubitemid 35416785)
19. J Guardia C Caso F Arias A Gual J Sanahuja M Ramirez I Mengual B Gonzalvo L Segura J Trujols M Casas 2002 A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial Alcohol Clin Exp Res 26 1381 1387 12351933 1:CAS:528:DC%2BD38XnsVWmurY%3D
20. SB Gulliver R Longabaugh D Davidson R Swift 2005 The development of a broad spectrum treatment for patients with alcohol dependence in early recovery. Adapting CBT for recalcitrant populations Cogn Behav Pract 12 53 63 10.1016/S1077-7229(05)80039-2 (Pubitemid 43227710)
21. HR Kranzler V Modesto-Lowe J Van Kirk 2000 Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial Neuropsychopharmacology 22 493 503 10731624 10.1016/S0893-133X(99)00135-9 1:CAS:528:DC%2BD3cXhvVOrtLg%3D (Pubitemid 30145617)
22. HR Kranzler J Van Kirk 2001 Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis Alcohol Clin Exp Res 25 1335 1341 11584154 10.1111/j.1530-0277.2001.tb02356.x 1:CAS:528:DC%2BD3MXnt1Git7o%3D
23. HR Kranzler DR Wesson L Billot Drug Abuse Sciences Naltrexone Depot Study Group 2004 Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial Alcohol Clin Exp Res 28 7 1051 1059 15252291 10.1097/01.ALC.0000130804.08397.29 1:CAS:528:DC%2BD2cXls1agsb8%3D (Pubitemid 38955203)
24. JH Krystal JA Cramer WF Krol GF Kirk RA Rosenheck 2001 Naltrexone in the treatment of alcohol dependence N Engl J Med 345 1734 1739 11742047 10.1056/NEJMoa011127 1:CAS:528:DC%2BD3MXovFKjs7s%3D (Pubitemid 34940228)
25. R Longabaugh PW Wirtz A Zweben RL Stout 1998 Network support for drinking, alcoholics anonymous and long-term matching effects Addiction 93 1313 1333 9926538 10.1046/j.1360-0443.1998.93913133.x 1:STN:280:DyaK1M7isFCmtg%3D%3D
26. R Longabaugh A Zweben JS Locastro WR Miller 2005 Origins, issues and options in the development of the combined behavioral intervention J Stud Alcohol 66 Suppl 15 179 187
27. AT McLellan AI Alterman DS Metzger GR Grissom GE Woody L Luborsky CP O'Brien 1994 Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services J Consul Clin Psychol 62 6 1141 1158 10.1037/0022-006X.62.6.1141 1:STN:280:DyaK2M7msVOlug%3D%3D (Pubitemid 24377643)
28. WR Miller PL Wilbourne 2002 Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders Addiction 97 3 265 277 11964100 10.1046/j.1360-0443.2002.00019.x (Pubitemid 34250721)
29. Miller WR, Rollnick S (1991) Motivational interviewing: preparing people to change addictive behavior. Guilford, New York
30. Miller WR, Rollnick S (2002) Motivational interviewing: preparing people to change, 2nd edn. Guilford, New York
31. Miller WR, Zweben A, diClemente CC, Rychtarik RG (1995) Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. National Institute on Alcohol Abuse and Alcoholism project MATCH monograph series 2. National Institute on Alcohol Abuse and Alcoholism, Rockville
32. JR Monterosso BA Flannery HM Pettinati DW Oslin M Rukstalis CP O'Brien JR Volpicelli 2001 Predicting treatment response to naltrexone: the influence of craving and family history Am J Addict 10 258 268 11579624 10.1080/ 105504901750532148 1:STN:280:DC%2BD3MrjtlWquw%3D%3D (Pubitemid 32879092)
33. PM Monti DJ Rohsenow RM Swift SB Gulliver SM Colby TI Mueller RA Brown A Gordon DB Abrams RS Niaura MK Asher 2001 Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes Alcohol Clin Exp Res 25 1634 1647 11707638 10.1111/j.1530-0277.2001. tb02170.x 1:CAS:528:DC%2BD3MXpt1Wnsbg%3D
34. SS O'Malley AJ Jaffe G Chang S Rode R Schottenfeld RE Meyer B Rounsaville 1996 Six-month follow-up of naltrexone and psychotherapy for alcohol dependence Arch Gen Psychiatry 53 217 224 8611058
35. SS O'Malley AJ Jaffe G Chang RS Schottenfeld RE Meyer B Rounsaville 1992 Naltrexone and coping skills therapy for alcohol dependence. A controlled study Arch Gen Psychiatry 49 881 887 1444726
36. SS O'Malley BJ Rounsaville C Farren K Namkoong R Wu J Robinson PG O'Connor 2003 Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials Arch Intern Med 163 1695 1704 12885685 10.1001/archinte.163. 14.1695 (Pubitemid 36898958)
37. DW Oslin KG Lynch HM Pettinati KM Kampman P Gariti L Gelfand T Ten Have S Wortman W Dundon C Dackis JR Volpicelli CP O'Brien 2008 A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention Alcohol Clin Exp Res 32 7 1299 1308 18540910 10.1111/j.1530-0277.2008.00698.x 1:CAS:528:DC%2BD1cXpvFGnuro%3D
38. Pettinatti HM, Weiss RD, Miller WR, Donovan D, Ernest DB, Rounsaville BJ (2004) Medical management (MM) treatment manual: a clinical research guide for medically trained clinicians providing pharmacotherapy as part of the treatment for alcohol dependence. National Institute on Alcohol Abuse and Alcoholism, Bethesda
39. Rapeli P, Service E, Salin PA 1997 Dissociation between simple and complex span impairment in alcoholics Memory 5 741 762 10.1080/741941549
40. RM Reitan 1958 Validity of the Trail-Making Test as an indicator of organic brain damage Percept Mot Skills 8 271 276 10.2466/PMS.8.7.271-276
41. C Rice R Longabaugh RA Stout 1997 Comparison sample validation of "your workplace": an instrument t measure alcohol support and consequences at work Addict Behav 22 711 722 9347072 10.1016/S0306-4603(97) 00002-6 1:STN:280:DyaK1c%2Fgs1Khsw%3D%3D (Pubitemid 27407448)
42. DJ Rohsenow 2004 What place does naltrexone have in the treatment of alcoholism? CNS Drugs 18 547 560 15222772 10.2165/00023210-200418090-00001 1:CAS:528:DC%2BD2cXmslWnsb4%3D (Pubitemid 38951778)
43. LC Sobell J Brown GI Leo MB Sobell 1996 The reliability of the alcohol timeline followback when administered by telephone and by computer Drug Alcohol Depend 42 49 54 8889403 10.1016/0376-8716(96)01263-X 1:STN:280: DyaK2s%2FksVegsA%3D%3D (Pubitemid 26300639)
44. MB Sobell LC Sobell F Klajner D Pavan E Basian 1986 The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research Addict Behav 11 149 161 3739800 10.1016/0306-4603(86)90040-7 1:STN:280:DyaL283pt1CmsA%3D%3D (Pubitemid 16039844)
45. GB Spanier 1976 Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads J Marriage Fam 38 15 28 10.2307/350547
46. LAR Stein PA Minugh R Longabaugh PW Wirtz 2009 Readiness to change as a mediator of the effect of a brief motivational intervention on post-treatment alcohol related consequences of injured emergency department hazardous drinkers Psychol Addict Behav 23 185 195 19586135 10.1037/a0015648 1:STN:280: DC%2BD1MvntlaltA%3D%3D
47. RM Swift W Whelihan O Kuznetsov G Buongiorno H Hsuing 1994 Naltrexone-induced alterations in human ethanol intoxication Am J Psychiatry 151 1463 1467 8092339 1:STN:280:DyaK2cznvFamtg%3D%3D
48. JR Volpicelli AI Alterman M Hayashida CP O'Brien 1992 Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry 49 876 880 1345133 1:STN:280:DyaK3s%2FnsVarsQ%3D%3D
49. JR Volpicelli KL Clay NT Watson CP O'Brien 1995 Naltrexone in the treatment of alcoholism: predicting response to naltrexone J Clin Psychiatry 56 Suppl 7 39 44 7673104
50. JR Volpicelli NT Watson AC King CE Sherman CP O'Brien 1995 Effect of naltrexone on alcohol "high" in alcoholics Am J Psychiatry 152 613 615 7694913 1:STN:280:DyaK2M3gvV2htw%3D%3D